We report the results ofa survey designed to investigate audiologic ref erral patterns of p rimar y care physicians and, more spe cifically, their ref erral of p atients fo r hearing aids and cochlear implants. Three hundred internal medicine and fa mily medicine physicians were identified fro m a ref erral basin of a tertiary care center and chosen randomly to befaxed questionnaires concerning their views about pati ents with hearing loss, hearing loss screening and ref erral practices, and availability oflocal resources. Of the 260 physicians who received a questionnaire, 85 (32.7%) responded. Of their communities (60% ofwhich had populations off ewer than 50,000), 82.4 % had an otolaryngologist and 40% had access to an academic center: Although 9 7.6 % of the responding physicians indicated that hearing loss affected pa tients' quality of life, only 60% assessedpatientsfor hearing loss. "Lack of time " and "more pressing issues" were the most common reasons givenfor not evaluating patientsf or hearing loss. Although 76 physicians (89.4%) said they were aware of cochlear implants, only 22 (25.9%) had referred patients for implant evaluation. Lack of ref erral most commonly resulted fr om uncertainties about "where to ref er " and "which patients were po tential candidates. " The results ofthis survey suggest that a large p ercentage ofprimary care physicians do not routinely test fo r hearing impairment in adults.
Introduction
As the population ages, more people have chronic health problems. Approximately 12.4% of the population is 65 years or older, and the segment older than 85 years has increased the most.1 Hearing loss is the third most common chronic condition in older adults, affecting between 25 and 40% of adults over the age of 65. 2 • 4 Decreased hearing has many implications for older adults. Hearing From the Department ofOtolaryngology, Vanderbi lt University Med ical Center, Nashv ille.
Repri nt reques ts: Robert F. Labadie loss has been associated with physical and psychosocial dysfunction , depression, and decreased we ll-bei ng ." ? However, auditory rehabilitation, with hearing aids and cochlear implants, can ameliorate the adverse effects of hearing impairment and increase patients' physical, social, and psychological function.v'? Primary care physicians (PCPs) have a unique opportunity to identify patients with hearing loss and direct them to appropriate treatment. They treat many chronic conditions, direct each patient' s health maintenance, and are usually the first physicians to learn of a new problem. Because hearing impairment may be underdiagnosed, recent work has emphasized the importance of screening and has described practical approaches for evaluating hearing IOSS . II. 12 By screening for hearing impairment, PCPs can uncover unrecognized cases and facilitate intervention. However, evaluating multiple chronic health problems and staying current with the ongoing improvements in hearing aids and the rapidly increasing field of cochlear implantation can be a difficult task. This study provides insights about the current state of hearing-loss screening among PCPs.
Materials and methods
After obtaining Institutional Review Board approval, a questionnaire was sent to PCPs practicing in a tertiary care referral basin. Physicians were identified by community visits, lists from local hospitals, continuing medical education programs, telephone books,and local medicalsocieties. This list of physicians is updated at least yearly and includes 1,581 physicians practicing intemal medicine and family medicine in 43 Kentucky and Tennessee counties.
A random sample of 300 physicians was selected, and each physician was faxed a questionnaire. If no response was received in I month, a second questionnaire was faxed; and if still no response was received, a third questionnaire was sent. Forty physicians who did not have a working fax machine were excluded, leaving 260 physicians.
Questions concerned the physician's practice setting, medical specialty, attitudes regarding hearing loss, method of evaluating patients for hearing loss, and referral of patients for hearing aids and cochlear implants. When a respondent did not answer a question, the response was noted as "no response." Questions were of the yes/no The foll owingtreatment-relatedadverseeventswereeachreported10 a sinqlepatient:tympanostomy tube blockage; ear pruritus; tinnitus; oral moniliasis; cryi ng; dizziness; anderyth ema. Acute Otitis Externa: The following treatment-related adve rse eventsoccurred in0.4% or more ofthepatients withint act tympa ni c membranes.
Pregnancy
Teratogenic Effects. Pregnancy Category C: Reproductionstudieshave been perf ormed inrats and mice using oral doses of upto 100mg/kg and IV doses up to 30 mg/kgand haverevealed no evidenceof harm to thefetus as a resul t of ciprolloxacin. ln rabbits, ciprofl oxaci n (30 and100mg/kgorally) producedqast rointestinal disturbances resulting in maternal weight loss and an increased incidence of abortion, but noteratoqerucrty wasobserved at either dose. After intravenous administration of doses upto 20 mg/kg, no maternal toxicity wasproduced in the rabbit, and no embryotoxicity orteratogen icity wasobserved.Corticosteroi dsaregenerallyteratogenic inlaboratoryanimals whenadministered systemicallyatrelativelylow dosage levels.The morepotent corticosteroids have beenshown tobeteratoge nic after dermal applicationinlaboratoryanimals. Anima l reproducti onstudie shave not been conducte dwith CIPRODEX' Otic. Noadequate andwell controlled studies have been performed in pregnant women. Cautionshoul d be exercise d whenCIPRO DEX' Otic is used bya pregnant woman. Nursing Mothers: Ci profloxacin and cortic osteroi ds, as a class, appear in milk following oral administration. Dexamethasone in breast mi lk could suppress growth, interfere with endogenous cort icosteroid production, or causeother untoward effects. It isnot knownwhether topical otic administratio n of ciprofl oxacinor dexamethasone could result in sufficient systemic abs orption to produ ce detectable quantities in hum an milk. Because of the potential forunwantedeffects in nursing infa nts. a decision should bemade whether to discontinuenursing or to discontinue thedrug, takinginto accountthe importance ofthe drugtothemother. Pediatric Use: The safety and efficacy of CIPROD EX' Otic have been established in pediatric patients6 months andolder 1937patients) in adequate and well-controlledclinicaltrials. Although no dataare avai lable onpatients lessthan age6 months, there arenoknown safety con cerns or differencesinthe disease pro cessinthispopulation that would preclude use of this product. ISee DOSAGE AND ADMINISTRATION.) No clinically relevant changesin hear ing function were observed in 69 pediatric pat ients(age 4 to 12 years) treated with CIPRODEX' Otic andtested for audiometric parameters. ADVERSE REACTIONS In Phases II and III clinical trials, a total of 937 patientswere treated with CIPROD EX' Oti c. This included 400 patientswith acute otitismediawith tympa nostomy tub esand 537pat ientswith acute otitis exte rna. The reported treatment -relatedadverse eve nts are listedbelow: Acute Otitis Media in pediatric patients with tympanostomy tubes: The following treatment-related adverse events occurred in0.5%or more ofthepatientswithnon-intact tympanic membranes. Ciprolloxacin, a lIuoroquinolone is availableasthe monohydrochloride monohydrate salt of l -cyclopropyl-6-fluoro-1A-dihydro-4-oxo-7-ll-piperazinyl)-3-quinol inecarboxylic acid. The empirical formul a is C17HI 8FN303·HCI·H20. Dexamethasone, 9-lIuoro-lli beta),17,21-trihydroxy-16(alpha)-methylpregna-1A-diene-3,20-dione, is an antiinttarnmatorv corticosteroid. The empirical formula is C22H29F0 5.
Alcon
CLINICAL PHARMACOLOGY Pharmacokinetics: Following a single bilateral 4-drop Itotal dose= 0. 28 mL, 0.84 mgciprolloxacin, 0.28 mgdexamet hasone) topical otic dose of CIPRODEX' Otic to pediat ric patients aftertympanostomy tubeinsertion, measurable pl asma concentrationsofciprofloxacinanddexamethasone were observed at 6 hoursfollowingadministrationin 2 of 9 patientsand5 of 9 pat ients, respe ctivel y. Mean ± SD peakplasma conce ntrat ionsof ciprolloxacin were 1. 39 ± 0.880ng/mL(n=9). Peak plasmaconcentrationsranged from0.543 ng/mLto 3.45ng/mLandwere onaverage approximate ly 0.1%of peak plasma concentrations achieved with anoral dose of250 -mg l~l . Peak plasma concentrations ofciprof loxacin were observed within 15minutes to 2hourspost dose application. Mean± SDpeakplasma concentrationsof dexamethasonewere 1.1 4 ± 1. 54 ng/mL (n=9). Peak plasma concentrations ranged from0.135 ng/mLto 5.10 ng/mL and were on average approximately 14% of peak conce ntrat ions reported in the literature following an oral 0.5-mg tablet dose"'. Peak pl asma concentrations of dexamethasone were observed within 15 mi nutes to 2 hours post dose applica tion. Dexamethasone has been adde d to aid in the resolutionofthe inflammatory response accompanying bacterial infection(such asotorrhea in pediatric patients with AOM with tympanostomytubes). 
Discussion
As the population ages , the prevalence of hearing loss and its adve rse effects on quality ofl ife and communication will esca late. Becau se hearing loss poses a sig nificant disease the physicians res ponded that they send pat ients back to the audiolog ist if the patients are unhapp y with their aids, 12.9% do not. Seventy-six res pondents (89 .4%) stated that they know about coc hlear imp lants, and 22 (25 .9%) refe r deafpatient s for eva luation. Eight of those who refer elderly adu lts stated that they have no age limit at which they stop referring. Of the 9 physicians who were unaware of cochlear impl ants, 5 had an audio logis t, an otolary ngo logist, and an aca demic center in their community. On e of the 9 had none of the above. Of the 73 respondents w ho do not refer patients for coc hlear implant eva luat ion, not know ing which patients are appropriate candidates or where to refer them were the most common reasons preventing referral (table 4) . Amo ng physicians with aca demic centers in their comm unities, 35.3% referred deaf patients to an otolary ngo logis t, compare d with 19.6% ofthose witho ut acade mic centers in their communities (p = 0.2, chi-square test). Of respondent s with local audio logists and otolary ngologists, 27.8% referred deafpatients for evaluation , compared with 15.4% of those without an audio log ist or oto laryngo logist (p = 0.7, Fisher Exac t Test). 
Results
Of the 260 ques tionnaires sent, 85 responses were rece ived, produ cing a res ponse rate of 32.7%. More than half ofall respo ndents were "Percentage calculated from the 34 respondents who do not evaluate hearing loss at aI/ from tow ns of fewer than 50,000 people, and or do so only occasionally. Respondents could give multipl e answers. one-fourth practiced in town s of more than 500,000 people. Ofth e respondents ' communities, 82.4% had an otolaryngologist, 67. 1% had Table 2 . Methods used by respondents to evaluate hearing loss an audiologis t, 40.0% had an academic center, Method and 12.9% had none of the above .
Among the respondents, 34 (40 .0%) reporte d that they do not routine ly eva luate their patient s for hearing loss. Among internal medicine physicians, 56. 1% scree n for hearing loss, com pared with 70.6% offamily medicine physic ians (p = 0.3, chi-square test). Lack of time and the prese nce of mor e important is-"Percentage calculated fro mthe 51 respondents who do evaluate hearing loss. Respondents could give multiple answers.
sues were the mos t comm on reasons given for not eva luating hearing loss (table I) . Of the respondents, 17.6% repo rted that they assess hearing loss only when a patient recog nizes a hearing problem ; 11.8% examine possibl e hearing loss at yea rly physicals; and 7.8% start inves tiga ting potent ial hearing impa irment at age 40, 5.9% at age 50, and 5.9% at age 65. Responses ind icated that vario us methods are used by PCPs whe n inves tiga ting patient s' hearing (tab le 2). A patient's reporting a change in hearing was the most common reaso n give n for referral to an aud iologis t or an otolary ngo logist (table 3) .
Of PCP s pract icing in towns with an academ ic center, 50% assessed patients for hear ing loss, compared with 66 .7% of PCPs practicing in towns without an aca dem ic center (p = 0.1 , chi-square test). Similarly, with respect to eva luating hearing loss, no statistically significant associations were see n between respondents ' having an audio log ist or an otolary ngo logist avai lable in the community (62 .2%) and their having neither an audio logis t nor an otolaryngo logist avai lable (45.5% ; P = 0.3, Fisher Exac t Test), or between PCP s practicing in town s of more than 500 ,000 peopl e (74.5%) and those practicing in towns offewer than 500,000 people (73 .5%; p = 0.9, chi-square test) .
All but two res ponde nts thought that hearing loss affected their patients ' quality of life. Among res pondents, 70 (82 .4%) thought patients with hearing aids were more likely to be socially active, 44 (5 1.8%) thought patient s were satisfied with their hearin g aids, and 8 (9.4%) thought patients were margin ally sat isfied. Although two-th irds of variety or allowed the respo ndent to choose one of the provided answe rs or wri te in a response . Data are prese nted in num eric for m and as a percentage. Sigm aStat 2.03 (SPSS, Inc.; Chicago) software wa s used to perform chi-square or Fisher Exac t Test analysis for categorical data.
CO HEN, LABA DIE, HAYNES burden and effective screening met hods and treatment options are avai lable , routine screening should be performed. I I Because PCPs are already involved in health promotion, they have the potential to identify elderly patients suffering from heari ng impairment. Th is study was undertaken to uncover PCPs ' attitudes regarding hearing loss and to identify the obstacles they face when referring impaired adults for treatment. Despite the res ulting dysfunct ion hearing loss presents, various obstacles prevented a large portion of PCP s in our study from reg ularly eval uat ing their elderly patients for hearing loss.
A lthough the American Academy of Fami ly Physicians recommends screening for hearing loss at yea rly physica ls,13 40.0% of respo ndents reported that they do not screen for hearing loss. Similarly, Logan etal found that 80% of'phys icians surveyed d id not routinely screen for hea ring loss in elde rly patients." Bess et al found that when patients do complain, on ly half are referred for management. 15 Thus, many potential patients with heari ng impairment do not receive the benefits ofaud itory rehabi litation. Respondents who had localaudio logists, otolaryngo logists, and academic centers were no more like ly to eva luate their patients for hearing loss than those wit hout these reso urces . Despite hav ing the means for auditory rehab ilitation within their communit ies, respondents were not taki ng fu ll advantage of these reso urces by identifying patients w ith impaired hearing and referring them for interventions.
Various screen ing met hods have bee n deve loped to assist PCPs in add ressing heari ng loss. Lichtenstein et al validated the use of a screen ing questionnaire and a portable audioscope-an otoscope with a bui lt-in audiomete r," No t on ly can the ear be examined wit h this device, but an estimate of hearing thres ho lds also can quickly be obt ained . The American Academy of Oto laryngology-Head and Neck Surgery also has developed a screening questio nnaire .FT he U.S . Preventive Services Task Force and other professional organizations, geriatric experts, and avai lab le literature recommend screening elderly patients wit h a combination ofquestionnaires and audiometry.I 1. 18 Subsequently,patients who require further evaluation of potential hea ring loss can be identified and direc ted to treatment.
Desp ite all these resources, only 40% of our respondents use some type of health-directed questionnaire and audiometric assessment (tab le 2) . Res ponses showe d that certain barriers prevented PCPs from inq uir ing abo ut hearing loss, altho ugh knowledge of the adverse impact of hearing impairment on patients' lives was evident amo ng respondents and most acknowledged that hearing loss affects their patients' qua lity of life. Respo ndents expressed that the practical aspects of screening patients deterred them from assessing patient s' hearing. Of the respondents who do not eva luate patients for hearing loss , almost 40 .0% stated that time constraints and other hea lth issues prevented them from screening patients (tab le I).
30 Additionally, despite the ava ilability of effective screening too ls, one-fo urth of respondents were not sure which me thod to use. To increase the freq uency of pr imary care screen ing , programs exp laining how to use the audioscope and discussing how to quickly identify patients requiri ng referral with questionna ires are still needed. Because many patients eit her do not discuss their hearing loss or do not accept it, active screening is essential. A study of2,304 hearing-impaired adults aged 50 an d older found that although patients not wearing hearing aids are more like ly to experience depression, anxiety, paranoia, and emotional prob lems compared w ith hearing aid users, many patients do not use heari ng aids ." Denial about needing hearing aids, be lieving aids wo uld not help, and the cost and stigma ofwearing heari ng aids prevented pat ients from inqui ring about them." Wilson et al also found that 55% of men admitted to some hearing loss, but on ly 12% sought help." Hence, some patients suffer unnecessarily wit h hearing impairment until they discuss the problem. Oto lary ngo logis ts must educate PCPs abou t the necessity ofsearching for hearing loss, counseling pat ients abo ut its adverse consequences, and directing them to care.
Furt hermore, teac hing PCPs abo ut treatable ca uses of hearing impairment can bring further benefit to patients. For example, routine physical examinations can uncover cerumen impaction. Sudden hearing loss, unilateral hearing loss , tympanic membrane perforations, and cholesteatoma may be recognized and referred to otolaryngologists for treatment." :" Additionally, patients with hearing aids need to be reassessed . Poorly fitting hearing aids, dead batteries, and poor patient dexterity are correctable causes of poor outcomes with hearing aids. " However, among our respondents, 12.9% make no recommendations to patients who report prob lems with their hearing aids and do not refer them back to audiologists or otolaryngologists. Discussing the limitations and benefits of hearing aids and asking about their effectiveness may help to reduce the social stigma of wearing an aid , minimize potential frustration, and identify patients with suboptimal improvement for reevaluation .
The need for increased education and outreach is most evident with respect to cochlear implantation. Almost 90% ofourrespondents were aware ofcochlear implants, but only one -fourth referred their deafpatients for evaluation. More than half of respondents who were not aware of cochlear implants practiced in towns that had an academic center, as well as a local audiologist and otolaryngologist. PCPs need to know that options exist for deaf patients and others who do not benefit from conventional hearing aids . Otherwise, a segment ofthe hearing-impaired community may continue to suffer. Otolaryngologists need to actively teach PCPs about cochlear implants. Most respondents said they did not refer patients for cochlear implants because they did not know which patients were candidates or where to send patients (table 4) . Surprisingly, fears about surgical risks and expenses were not common barriers to referral.
Through community lectures and educational programs, both patients and PCPs could be exposed to advances in hearing aids and cochlear implants, identification oflikely candidates, and the resources available. Howe ver, 17.6% of our physicians did not have access to an otolaryngologist, and 32.9% did not have an audiologist in their community. Continued outreach from otolaryngologists and audiologists is essential to maximize the treatment ofhearing loss . Furthermore, residents in primary care specialties could rotate through otolaryngology to increase their comfort level in evaluating hearing impairment. Using a team approach , otolaryngolgists, audiologists, and PCPs must take the initiative in managing this wide spread source of physical, social, and psychological dysfunction .
A few points regarding stud y design are relevant. First, certain questions might have been misinterpreted, and the answer choices provided might have influenced the responses given. Respondents might have been unwilling to admit that they did not evaluate hearing loss or that they were not aware of cochlear implants, underestimating these results. Because only one -fourth of respondents Volume 84, Number 1 practiced in towns with more than 500 ,000 people, this study may not adequately represent PCPs in larger cities. Similarly, the results might have been different if more than 40.0% of respondents had academic centers in their communities.
Finally, our response rate (32.7 %) reduces our ability to draw firm generalizations about PCPs' screening for hearing loss . Because data from nonresponders could not be collected, a sensitivity ana lysis comparing responders and nonresponders is not possible. Therefore, the extent to which responders were similar to nonresponders is not known . Attempts were made to examine a representative group within the primary care community.A random sample of PCPs was selected, and questionnaires were sent three times to maximize the response rate. Despite its limitations, this study provides insights about how PCPs address hearing loss among the elderly and the barriers that exist in referring patients for intervention.
Conclusions
The potential exists to improve the means of evaluating adults, especially elderly patients, for hearing loss. As the primary patient advocates, PCPs must play an essential role in identifying patients with hearing loss and referring them for intervention. However, otolaryngologists and audiologists need to advocate for hearing-impaired patients and educate PCPs about the continually improving technology designed for auditory rehabilitation. Furthermore, screening techniques, basic disease entities, and therapeutic options should be part of the curriculum for residents in family medicine. Exciting advances in the field of hearing aids and cochlear implants bring increased advantages for patients. Future efforts should focus on developing screening programs, determining their effectiveness, and studying patient benefit from continually improving hearing aids and cochlear impl ants. LLOYD, ALMEYDA, 01 C UFFA, SHAH These studies will include an investigation ofthe long-term effects on the structure and function ofcartilage associ ated with the tendency (although small) of extracellular matrix deposition to incre ase in intensity and depth according to the du ration of silver nitrate exposure.
